Scripps’s President Steps Down

Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, ELIFE SCIENCES PUBLICATIONS LTD.Talks between the Scripps Research Institute (TSRI) and the University of Southern California (USC) about a possible merger fizzled out earlier this month, but the damage was done. Michael Marletta, Scripps’s president has resigned after faculty members across the organization voiced their opposition to a partnership with USC and their lack of confidence in his leadership.

“I think we are more optimistic than we have been in many years, because we feel like we have some control over our own fate,” Scripps biologist Jeanne Loring told Nature News.

In a brief statement, Richard Gephardt, chair of TSRI’s Board of Trustees said “the Board is working with Dr. Marletta on a possible transition plan. . . . Any such transition will engage all key constituencies in a dialogue about the future direction of this storied institution.”

On top of the USC kerfuffle, Marletta was also dealing with a $21 million deficit this year. Marletta’s tenure as president began in January 2012.

Update (August 11): TSRI’s Boart of Trustees today announced its appointment of James Paulson as interim president and CEO. Paulson, chair ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies